Patents by Inventor Haren Vasavada

Haren Vasavada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200165593
    Abstract: Disclosed are methods and compositions for treating propionic academia based on mRNA therapy.
    Type: Application
    Filed: July 20, 2018
    Publication date: May 28, 2020
    Inventors: Susan Sobolov-Jaynes, Romesh R. Subramanian, Judith L. Campagnari, Haren Vasavada, Zhiliang Cheng
  • Publication number: 20190307857
    Abstract: The invention relates to methods and compositions for treating a UDP glucuronosyltransferase family 1 deficiency based on mRNA therapy.
    Type: Application
    Filed: December 9, 2016
    Publication date: October 10, 2019
    Applicant: ModernaTX, Inc.
    Inventors: Melissa Lasaro, David Osterman, Haren Vasavada, Christian Cobaugh
  • Publication number: 20050215489
    Abstract: Methods of the invention relate to treatment of diabetes, particularly type 2 diabetes, and related disorders by administration of a PDE11A inhibitor. Such PDE11A inhibitors may be administered in conjunction with alpha-glucosidase inhibitors, insulin sensitizers, insulin secretagogues, hepatic glucose output lowering compounds, beta3 agonist or insulin. Such PDE11A inhibitors may also be administered in conjunction with body weight reducing agents. Further methods of the invention relate to stimulating insulin release from pancreatic cells, particularly in response to an elevation in blood glucose concentration, by administration of a PDE11A inhibitor.
    Type: Application
    Filed: March 14, 2003
    Publication date: September 29, 2005
    Applicant: Bayer Pharmaceuticals Corporation
    Inventor: Haren Vasavada